What Drives Newly Minted Crispr Unicorn Mammoth Biosciences Mammoth Biosciences has raised $195 million to build next-generation CRISPR products in therapeutics and diagnostics that can cure and detect diseases. Mammoth has now reached unicorn status in the industry with a valuation of more than $1 billion.